We are live on ! Find out more
GC

Globeflex Capital Portfolio holdings

AUM $661M
1-Year Est. Return 50.59%
This Fund
S&P 500
This Quarter Est. Return
+7.43%
1 Year Est. Return
+50.59%
3 Year Est. Return
+135.47%
5 Year Est. Return
+202.82%
10 Year Est. Return
+1,069.65%
AUM
$557M
AUM Growth
+$8.06M
Cap. Flow
-$17.4M
Cap. Flow %
-3.12%
Top 10 Hldgs %
15.98%
Holding
514
New
65
Increased
139
Reduced
63
Closed
62

Top Buys

Rank Stock Value
1
OVID icon
Ovid Therapeutics
OVID
+$3.98M
2
AMRX icon
Amneal Pharmaceuticals
AMRX
+$2.56M
3
SIGA icon
SIGA Technologies
SIGA
+$2.52M
4
III icon
Information Services Group
III
+$1.69M
5
RVI
Retail Value Inc. Common Shares
RVI
+$1.67M

Top Sells

Rank Stock Value
1
ACH
Accendra Health
ACH
+$5.72M
2
UCTT
Ultra Clean Holdings
UCTT
+$2.82M
3
MITK icon
Mitek Systems
MITK
+$2.11M
4
BLDR icon
Builders FirstSource
BLDR
+$2.1M
5
MEDP icon
Medpace
MEDP
+$2M

Sector Composition

Rank Sector Weight
1 Healthcare 19.86%
2 Industrials 16.1%
3 Technology 15.87%
4 Financials 14.48%
5 Consumer Discretionary 11.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GHL
301
DELISTED
Greenhill & Co., Inc.
GHL
$418K 0.08%
26,885
– –
LTC
302
LTC Properties
LTC
$2.13B
$414K 0.07%
10,791
-2,824
-21% -$115K
HNI icon
303
HNI Corp
HNI
$3.08B
$410K 0.07%
9,327
-12,365
-57% -$536K
FICO icon
304
Fair Isaac
FICO
$31.8B
$405K 0.07%
806
– –
MOV icon
305
Movado Group
MOV
$840M
$405K 0.07%
12,864
– –
PGTI
306
DELISTED
PGT, Inc.
PGTI
$403K 0.07%
17,364
– –
LE icon
307
Lands' End
LE
$378M
$399K 0.07%
+9,729
New +$266K
WAT icon
308
Waters Corp
WAT
$37.3B
$384K 0.07%
+1,111
New +$352K
MCK icon
309
McKesson
MCK
$104B
$383K 0.07%
2,002
– –
COR icon
310
Cencora
COR
$62B
$381K 0.07%
3,329
– –
TROW icon
311
T. Rowe Price
TROW
$25.5B
$380K 0.07%
1,920
-5
-0.3% -$935
PRDO icon
312
Perdoceo Education
PRDO
$2.17B
$377K 0.07%
30,765
+169
+0.6% +$2.06K
MTD icon
313
Mettler-Toledo International
MTD
$28.1B
$375K 0.07%
+271
New +$350K
ACCS
314
ACCESS Newswire
ACCS
$26.4M
$372K 0.07%
+13,718
New +$354K
EBS icon
315
Emergent Biosolutions
EBS
$379M
$370K 0.07%
5,878
-9,580
-62% -$615K
SSNC icon
316
SS&C Technologies
SSNC
$18.9B
$369K 0.07%
5,123
– –
JEF icon
317
Jefferies Financial Group
JEF
$12.7B
$367K 0.07%
+11,213
New +$342K
JHG
318
DELISTED
Janus Henderson
JHG
$367K 0.07%
9,464
– –
COWN
319
DELISTED
Cowen Inc. Class A Common Stock
COWN
$367K 0.07%
8,950
– –
CDW icon
320
CDW
CDW
$18.9B
$366K 0.07%
2,093
– –
HIW icon
321
Highwoods Properties
HIW
$3.79B
$365K 0.07%
8,088
– –
LH icon
322
Labcorp
LH
$25.2B
$363K 0.07%
+1,531
New +$349K
CTG
323
DELISTED
Computer Task Group, Inc.
CTG
$362K 0.07%
37,448
– –
GPX
324
DELISTED
GP Strategies Corp.
GPX
$362K 0.07%
23,043
– –
MBIN icon
325
Merchants Bancorp
MBIN
$2.49B
$361K 0.06%
13,799
– –
11 12
13
14 15

Similar funds

RCG
Regatta Capital Group El Segundo, California $661M AUM 17.85% 1-Year Est. Return
FM
Freemont Management Vaud, Switzerland $661M AUM 60.48% 1-Year Est. Return
ACM
Arosa Capital Management Miami Beach, Florida $660M AUM 210.26% 1-Year Est. Return
UCMOK
United Capital Management of KS Salina, Kansas $660M AUM 50.85% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
FAM
Fulcrum Asset Management London, United Kingdom $662M AUM 48.09% 1-Year Est. Return
CAM
Chandler Asset Management San Diego, California $659M AUM 11.68% 1-Year Est. Return
AWA
Artemis Wealth Advisors New York $662M AUM 39.67% 1-Year Est. Return

Globeflex Capital's Q2 2021 Portfolio in Review

As of Q2 2021, Globeflex Capital held 514 positions worth $557M, up 1.5% from $549M the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Globeflex Capital withdrew a net $17.4M in Q2 2021, closing 62 positions and reducing 63 holdings. Its most notable exit was Perficient Inc, an estimated $1.89M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, up from 18% a quarter earlier, followed by Industrials and Technology.

Against the trend, Globeflex Capital opened a new position in Ovid Therapeutics worth $3.95M.

  • Globeflex Capital's largest Q2 2021 buy was Ovid Therapeutics: 1,009,125 shares worth $3.95M.
  • Globeflex Capital added most to Amneal Pharmaceuticals in Q2 2021, an estimated $2.56M increase.
  • Globeflex Capital's biggest Q2 2021 reduction was Accendra Health, cutting an estimated $5.72M.
  • Globeflex Capital fully exited Perficient Inc in Q2 2021, selling an estimated $1.89M.
  • Globeflex Capital's ten largest holdings make up 16% of its $557M portfolio in Q2 2021.
  • Globeflex Capital opened 65 new positions and closed 62 in Q2 2021.
  • Globeflex Capital's portfolio value rose 1.5% quarter-over-quarter to $557M.

Based on Globeflex Capital's 13F filing for Q2 2021, filed 12 Aug 2021.